TRxADE HEALTH Announces Recently Merged Superlatus Will Acquire The Urgent Company; Terms Not Disclosed
Portfolio Pulse from Benzinga Newsdesk
TRxADE HEALTH has announced that its recently merged entity, Superlatus, will acquire The Urgent Company. The terms of the deal have not been disclosed.
August 22, 2023 | 12:08 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
TRxADE HEALTH, listed as MEDS, has announced an acquisition through its merged entity, Superlatus. The impact on the stock is uncertain due to undisclosed deal terms.
Acquisitions can have a significant impact on a company's stock price. However, without the terms of the deal, it's difficult to predict the exact impact on MEDS. The acquisition could lead to increased revenues and growth, but it could also lead to increased expenses and risks.
CONFIDENCE 70
IMPORTANCE 75
RELEVANCE 100